Effect of neoadjuvant alternating taxane- and anthracycline-based dose-dense regimen for operable breast cancer on prognosis in triple-negative tumors with a complete histological response. Background ...
Multicenter, Randomized, Phase II Trial of CI-1033, an Irreversible Pan-ERBB Inhibitor, for Previously Treated Advanced Non–Small-Cell Lung Cancer The difference in median TTP, overall survival, and ...
The relationship between how much NF-κB is in the nucleus versus how much of it does its job on DNA becomes straightforward when applying these methods. This allowed Reeves and the team to evaluate ...
COLD SPRING HARBOR, N.Y. (May 25, 2010) --NF-κB is a critical signaling molecule in the immune system that regulates cell survival and cell death, lymphocyte responses, and inflammation. Acting as a ...
Researchers at National Taiwan University Hospital in Taipei have conducted a study demonstrating the potential effectiveness of a novel drug combination at reducing morbidity and mortality in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results